I conduct research on central nervous system disorders using animal models such as mice, rats, and zebrafish. My scientific interests focus on screening newly synthesized compounds and natural substances, with particular emphasis on their potential applications in the treatment of epilepsy, as well as depression, anxiety, addiction, and memory-related processes. Recently, I have also been interested in molecular biology and personalized medicine, particularly in the context of drug-induced epigenetic changes.